June 9 (Reuters) - The U.S. Chamber of Commerce on Friday sued the federal government, challenging a new law that for the first time gives Medicare the power to negotiate drug prices with pharmaceutical companies.
In a complaint filed in federal court in Dayton, Ohio, the chamber said the pricing program violated drugmakers' due process rights under the U.S. Constitution by giving the government "unfettered discretion" to dictate maximum prices.
Other drugmakers have also objected to the pricing program, which is part of last year's Inflation Reduction Act.
The chamber also warned that allowing the pricing program would set a bad precedent.
The case is Dayton Area Chamber of Commerce et al v Becerra et al, U.S. District Court, Southern District of Ohio, No.
Persons:
Biden, Karine Jean, Pierre, Neil Bradley, Becerra, Jonathan Stempel, Bill Berkrot
Organizations:
U.S . Chamber, Commerce, U.S, U.S . Department of Health, Human Services, Medicare, Medicaid Services, Merck & Co, CMS, Merck, Dayton Area, Court, Southern District of, Thomson
Locations:
Dayton , Ohio, Washington ,, Dayton, U.S, Southern District, Southern District of Ohio, New York